Condition
Impaired Renal Function
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownDapagliflozin Treatment in Type 2 DiabetesNCT04620590 · 2021-04-20
COMPLETEDLinagliptin's Effect on CD34+ Stem CellsNCT02467478 · 2015-04-01
COMPLETEDEffects of Obesity Surgery on Renal FunctionNCT01507350 · 2011-06-01
COMPLETEDPlatelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering TreatmentNCT01035320 · 2006-01-01
COMPLETEDCommon interventions
Leading sponsors
Trial status mix
COMPLETED4
Phase mix
PHASE43
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.